Vitamins C and Vitamin E and Cardiovascular Risk

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2007

Study Completion Date

March 31, 2008

Conditions
Diabetes
Interventions
DIETARY_SUPPLEMENT

Study Arm A

Control: no vitamins (placebo only). This study will provide baseline metabolic and surrogate marker changes that are caused by the high fat meal. Study arms B, C, and D will be statistically compared to this study.

DIETARY_SUPPLEMENT

Study Arm B

This study arm will provide information on the response of atherogenic surrogate markers to a high fat supper when a low dosage form of vitamin C is administered (250 mg) and Vitamin E (200 IU).

DIETARY_SUPPLEMENT

Study Arm C

This study arm will provide information on the response of atherogenic surrogate markers to a high fat supper when a medium dosage form of vitamin C administered (500 mg)and Vitamin E (400 IU).

DIETARY_SUPPLEMENT

Study Arm D

This study arm will provide information on the response of atherogenic surrogate markers to a high fat supper when a high dosage form of vitamin C is administered (1000 mg) and Vitamin E (800 IU).

Trial Locations (1)

87131

University of New Mexico Health Sciences Center, Albuquerque

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

University of New Mexico

OTHER

NCT00362518 - Vitamins C and Vitamin E and Cardiovascular Risk | Biotech Hunter | Biotech Hunter